Who Should Receive Extended Infusion Beta-Lactam Therapy?

Authors

Christopher T. Roman, Butler UniversityFollow
Tia Sloth
Kendra M. Damer, Butler UniversityFollow

Document Type

Article

Publication Date

2016

Publication Title

Journal of the American Academy of Physician Assistants

First Page

25

Last Page

26

DOI

http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88

Abstract

The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.

Rights

Version of record can be found through LWW.

Recommended Citation

Roman, Christopher T.; Sloth, Tia; and Damer, Kendra M., "Who Should Receive Extended Infusion Beta-Lactam Therapy?" (2016). Scholarship and Professional Work – COPHS. 159.
https://digitalcommons.butler.edu/cophs_papers/159